Hypnotherapy for treatment of irritable bowel syndrome

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Webb, Annette N ^a   Kukuruzovic, R H ^b   Catto Smith, A G ^b   Sawyer, S M ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b NONE

Author keywords

*Hypnosis; Female; Humans; Irritable bowel syndrome psychology; *therapy ; Male; Randomized controlled trials as topic

Indexed keywords

ABDOMINAL PAIN; BLOATING; CLINICAL TRIAL; COGNITIVE THERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DATA EXTRACTION; DIARRHEA; DISEASE SEVERITY; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; IRRITABLE COLON; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT COUNSELING; PSYCHOTHERAPY; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 44949156415     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005110.pub2     Document Type: Review

References (49)

1. Galovski 1998 {published data only} Galovski TE, Blanchard EB. The treatment of irritable bowel syndrome with hypnotherapy. Appl Psychophysiol Biofeedback 1998;23(4):219-32.
2. Palsson 2002a {published data only} Palsson OS, Turner MJ, Johnson DA, Burnett CK, Whitehead WE. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci 2002;47(11):2605-14.
3. Roberts 2006 {published data only} Roberts L, Wilson S, Singh S, Roalfe A, Greenfield S. Gut directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. Br J Gen Pract 2006;56(523):115-21.
4. Whorwell 1984 {published data only} Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984;2(8414):1232-4.
5. Barabasz 2006 Barabasz A, Barabasz M. Effects of tailored and manualized hypnotic inductions for complicated irritable bowel syndrome patients. Int J Clin Exp Hypn 2006;54(1):100-12.
6. Boyce 2003 Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol 2003;98(10):2209-18.
7. Flammer 2003 Flammer E, Bongartz W. On the efficacy of hypnosis: A meta-analytic study. Contemporary Hypnosis 2003;20(4):179-97.
8. Forbes 2000 Forbes A, MacAuley S, Chiotakakou-Faliakou E. Hypnotherapy and therapeutic audiotape: effective in previously unsuccessfully treated irritable bowel syndrome?. Int J Colorectal Dis 2000;15(5-6):328-34.
9. Gonsalkorale 2003 Gonsalkorale WM, Miller V, Afzal A, Bhuket T, Chey W. Hypnotherapy for irritable bowel syndrome: Effectively expanding the arsenal?. Evidence-Based Gastroenterology 2004;5(2):54-5.
10. Gonsalkorale 2004 Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res 2004;56(3):271-8.
11. Harvey 1989 Harvey RF, Hinton RA, Gunary RM, Barry RE. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet 1989;1(8635):424-5.
12. Houghton 1996 Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome - the effect of hypnotherapy. Aliment Pharmacol Ther 1996;10(1):91-5.
13. Lea 2003 Lea R, Houghton LA, Calvert EL, Larder S, Gonsalkorale WM, Whelan V, et al.Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003;17(5):635-42.
14. Palsson 2002b Palsson OS, Turner MJ, Johnson DA, Burnett CK, Whitehead WE. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci 2002;47(11):2605-14.
15. Palsson 2006 Palsson OS, Turner MJ, Whitehead WE. Hypnosis home treatment for irritable bowel syndrome: a pilot study. Int J Clin Exp Hypn 2006;54(1):85-99.
16. Prior 1989 Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut 1990;31(8):896-8.
17. Roy 1995 Roy JL. Hypnotherapy and refractory irritable bowel syndrome [Hypnotherapie et syndrome de l'intestin irritable refractaire]. Revue Francaise de Gastro-Enterologie 1995;31(310):863-7.
18. Schafer 1997 Schafer DW. Hypnosis and the treatment of ulcerative colitis and Crohn's disease. Am J Clin Hypn 1997;40(2):111-7.
19. Simren 2004 Simren M, Ringstrom G, Bjornsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med 2004;66(2):233-8.
20. Stockbrugger 1999 Stockbrugger R, Coremans G, Creed F, Dapoigny M, Muller-Lissner SA, Pace F, et al.Psychosocial background and intervention in the irritable bowel syndrome. Digestion 1999;60(2):175-86.
21. Taylor 2004 Taylor EE, Read NW, Hills HM. Combined group cognitive-behaviour therapy and hypnotherapy in the management of the irritable bowel syndrome: The feasibility of clinical provision. Behavioural & Cognitive Psychotherapy 2004;32(1):99-106.
22. Vidakovic-Vukic 1999 Vidakovic-Vukic M. Hypnotherapy in the treatment of irritable bowel syndrome: methods and results in Amsterdam. Scand J Gastroenterol Suppl 1999;230:49-51.
23. Whorwell 1987 Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut 1987;28(4):423-5.
24. Whorwell 1991 Whorwell PJ. Use of hypnotherapy in gastrointestinal disease. Br J Hosp Med 1991;45(1):27-9.
25. Zimmerman 2003 Zimmerman J. Cleaning up the river: a metaphor for functional digestive disorders. Am J Clin Hypn 2003;45(4):353-9.
26. Blanchard 1988 Blanchard EE, Schwartz SP. Clinically significant changes in behavioral medicine. Behav Assess 1988;10:171-88.
27. Camilleri 2000 Camilleri M, Williams DE. Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures. Pharmacoeconomics 2000;17(4):331-8. [MEDLINE: 10947488].
28. Coates 2004 Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, et al.Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004;126(7):1657-64.
29. Dinges 1997 Dinges DF, Whitehouse WG, Orne EC, Bloom PB, Carlin MM, Bauer NK, et al.Slef-hypnosis training as an adjunctive treatment in the management of pain associated with sickle cell disease. Int J Clin Exp Hypn 1997;45(4):417-32.
30. Drossman 1997 Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997;112(6):2120-37. [MEDLINE: 9178709].
31. Drossman 2000 Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, et al.Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000;95(4):999- 1007.
32. Drossman 2006a Drossman, DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130(5): 1377-90.
33. Drossman 2006b Drossman DA, Corrazziari E, Delvaux M, Spiller R, Talley NJ, Thompson WG, et al.Rome III: The functional gastrointestinal disorders. McLean, VA: Degnon Associates, 2006.
34. Francis 1997 Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997;11(2):395- 402.
35. Gralnek 2000 Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119(3):654-60. [MEDLINE: 10982758].
36. Jones 2000 Jones J, Boorman J, Cann P, Forbes A, Gomborone J, Heaton K, et al.British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000;47 Suppl 2:ii1-19.
37. Lesbros 2004 Lesbros-Pantoflickova D, Michetti P, Fried M, Beglinger C, Blum AL. Meta-analysis: The treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004;20(11-12):1253-69.
38. Lin 2004 Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004;292(7):852-8.
39. Manning 1978 Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2(6138):653-4.
40. Mayer 2005 Mayer EA, Berman S, Suyenobu B, Labus J, Mandelkern MA, Naliboff BD, et al.Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain 2005;115(3):398-405.
41. Mitchell 1987 Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 1987;92(5 Pt 1):1282-4. [MEDLINE: 3557021].
42. Olness 1987 Olness K, MacDonald JT, Uden DL. Comparison of slef-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 1987;79(4):593-7.
43. Rainville 1997 Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997;277(5328):968-71.
44. Stacher 1975 Stacher G, Berner P, Naske R, Schuster P, Bauer P, Starker H, et al.Effect of hypnotic suggestion of relaxation on basal and betazole-stimulated gastric acid secretion. Gastroenterology 1975;68(4 Pt 1):656-61. [MEDLINE: 235479].
45. Sugarman 1996 Sugarman LI. Hypnosis: teaching children self-regulation. Pediatr Rev 1996;17(1):5-11. [MEDLINE: 8559717].
46. Talley 2002 Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease?. Lancet 2002;360(9332): 555-64.
47. Thompson 1989 Thompson WG, Dotevall G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: Guidelines for the diagnosis. Gastroenterology International 1989;2(2):92-5.
48. Thompson 1999 Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45 Suppl 2:II43-7.
49. Zeltzer 1984 Zeltzer L, LeBaron S, Zeltzer PM. The effectiveness of behavioral intervention for reduction of nausea and vomiting in children and adolescents receiving chemotherapy. J Clin Oncol 1984;2(6):683-90.